From our analysis, DSG1, KDR, and SERPINB3 expression may have potential as robust markers that can risk-stratify cervical disease, i.e., identify cervical disease cases that have a high probability of regression, and this would be of significant clinical value. Here, SERPINB3 is linked to cervicitis.